PURPOSE: Neuron-specific enolase (NSE) concentrations are prognostic following traumatic and anoxic brain injury and may provide a method to quantify neuronal injury in other populations. We determined the association of admission plasma NSE concentrations with mortality and delirium in critically ill septic patients. METHODS: We performed a retrospective analysis of 124 patients from a larger sepsis cohort. Plasma NSE was measured in the earliest blood draw at intensive care unit admission. Primary outcomes were 30-day mortality and intensive care unit delirium determined by chart review. RESULTS: Sixty-one patients (49.2%) died within 30 days, and delirium developed in 34 (31.5%) of the 108 patients who survived at least 24 hours and were not persistently comatose. Each doubling of the NSE concentration was associated with a 7.3% (95% confidence interval [CI] 2.5-12.0, P= .003) increased risk of 30-day mortality and a 5.2% (95% CI 3.2-7.2, P< .001) increased risk of delirium. An NSE concentration >12.5 μg/L was independently associated with a 23.3% (95% CI 6.7-39.9, P= .006) increased risk of 30-day mortality and a 29.3% (95% CI 8.8-49.8, P= .005) increased risk of delirium. CONCLUSIONS: Higher plasma NSE concentrations were associated with mortality and delirium in critically ill septic patients, suggesting that NSE may have utility as a marker of neuronal injury in sepsis.
PURPOSE:Neuron-specific enolase (NSE) concentrations are prognostic following traumatic and anoxic brain injury and may provide a method to quantify neuronal injury in other populations. We determined the association of admission plasma NSE concentrations with mortality and delirium in critically ill septicpatients. METHODS: We performed a retrospective analysis of 124 patients from a larger sepsis cohort. Plasma NSE was measured in the earliest blood draw at intensive care unit admission. Primary outcomes were 30-day mortality and intensive care unit delirium determined by chart review. RESULTS: Sixty-one patients (49.2%) died within 30 days, and delirium developed in 34 (31.5%) of the 108 patients who survived at least 24 hours and were not persistently comatose. Each doubling of the NSE concentration was associated with a 7.3% (95% confidence interval [CI] 2.5-12.0, P= .003) increased risk of 30-day mortality and a 5.2% (95% CI 3.2-7.2, P< .001) increased risk of delirium. An NSE concentration >12.5 μg/L was independently associated with a 23.3% (95% CI 6.7-39.9, P= .006) increased risk of 30-day mortality and a 29.3% (95% CI 8.8-49.8, P= .005) increased risk of delirium. CONCLUSIONS: Higher plasma NSE concentrations were associated with mortality and delirium in critically ill septicpatients, suggesting that NSE may have utility as a marker of neuronal injury in sepsis.
Authors: Timothy D Girard; James C Jackson; Pratik P Pandharipande; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Sharon M Gordon; Angelo E Canonico; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Crit Care Med Date: 2010-07 Impact factor: 7.598
Authors: Nada S Al-Qadheeb; Ethan M Balk; Gilles L Fraser; Yoanna Skrobik; Richard R Riker; John P Kress; Shawn Whitehead; John W Devlin Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Lynn McNicoll; Margaret A Pisani; Ying Zhang; E Wesley Ely; Mark D Siegel; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2003-05 Impact factor: 5.562
Authors: Yahya Shehabi; Rinaldo Bellomo; Michael C Reade; Michael Bailey; Frances Bass; Belinda Howe; Colin McArthur; Ian M Seppelt; Steve Webb; Leonie Weisbrodt Journal: Am J Respir Crit Care Med Date: 2012-08-02 Impact factor: 21.405
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Nuala J Meyer; John P Reilly; Rui Feng; Jason D Christie; Stanley L Hazen; Carolyn J Albert; Jacob D Franke; Celine L Hartman; Jane McHowat; David A Ford Journal: JCI Insight Date: 2017-12-07
Authors: Mayur B Patel; Josef Bednarik; Patricia Lee; Yahya Shehabi; Jorge I Salluh; Arjen J Slooter; Kate E Klein; Yoanna Skrobik; Alessandro Morandi; Peter E Spronk; Andrew M Naidech; Brenda T Pun; Fernando A Bozza; Annachiara Marra; Sayona John; Pratik P Pandharipande; E Wesley Ely Journal: Crit Care Med Date: 2018-11 Impact factor: 7.598
Authors: Brian J Anderson; Christopher F Chesley; Miranda Theodore; Colin Christie; Ryan Tino; Alex Wysoczanski; Kristy Ramphal; Michelle Oyster; Laurel Kalman; Mary K Porteous; Christian A Bermudez; Edward Cantu; Dennis L Kolson; Jason D Christie; Joshua M Diamond Journal: J Heart Lung Transplant Date: 2018-02-02 Impact factor: 10.247
Authors: Vineet K Raghu; Christopher M Horvat; Patrick M Kochanek; Ericka L Fink; Robert S B Clark; Panayiotis V Benos; Alicia K Au Journal: Pediatr Crit Care Med Date: 2021-10-01 Impact factor: 3.971
Authors: Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent Journal: Crit Care Date: 2020-06-05 Impact factor: 9.097